News About: Pharm. Industry
Lilly Korea names new CEO
Lilly Korea said yesterday it has named Paul Henry Huibers as new president as of March 1 as a new president.
Huibers, 47, had a long career with Eli Lilly in his native Netherlands as well as in the U.S. and Portu...
Local drugmakers urged to be ‘same boat’ over drug price-cut plan
The Korea Pharmaceutical Manufacturers Association is considering legal action to prevent the government’s plan slash the price of about half the drugs on the market by an average of 14 percent, which was announced on...
Experts calls for more active new drug development
The government’s plan to slash insurance-covered drug prices in April would establish grounds to reinforce fundamentals of the Korean drug sector and to shift from generic manufacturing to novel pharmaceutical innovat...
Establishment of two pharma-star graduate schools eyed
The government plans to support the establishment of two pharma-star graduate schools in the latter half of this year in Seoul and other metropolitan area as part of efforts to nurture global licensing and regulatory ...
Korea's pharmaceutical imports top $2.93 billion in 2011
Korea’s imports of pharmaceutical products stood at $2.93 billion last year, up $400 million from a year earlier, the Korea Pharmaceutical Traders Association said yesterday.
Imports of finished drugs posted $2.66 ...
Korean drug makers shy of M&As
The government plans to ease regulations to promote the development of innovative medicine and medical treatments, as well as encourage mergers and acquisitions (M&As) among pharmaceutical firms in order to make them ...
Dong-A’s top 19 flagship products account for 68% in 2011 sales
Dong-A Pharmaceutical Co. said recently that it garnered 68 percent of its sales from 19 leading drugs last year.
The combined sales of the 19 flagship drugs stood at 620.8 billion won from the company’s gross reve...
Local drug makers to file individual suit against government
An individual action lawsuit opposing the government’s price-cut plan is expected to be filed in the middle of next month at the latest, the Korea Pharmaceutical Manufacturers Association said.
The government plans...
Government to boost SK Biopharm’s epilepsy drug development
The government has recently unveiled its plan to support SK Biopharmaceuticals’ new epilepsy drug as part of its efforts to nurture blockbuster drugs, targeting the international market.
The company has since 2006 ...
Battle gets fiercer over impotence drug market
Local drug makers are expected to wage fiercer campaigns to raise their impotence drug market share as the patent of an impotence medicine Viagra t is due to expire in May 17.
The domestic market for erectile dysfu...
